Complications of diabetes can have numerous negative health effects, from impaired vision and nerve damage to kidney dysfunction and heart disease. In an analysis of information on adults with colorectal cancer, patients who also had diabetes-;particularly those with diabetic complications-;faced a higher risk of dying early.
Reviewed by Megan Craig, M.Sc.Oct 24 2023 The results are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Compared with individuals without diabetes, those with uncomplicated diabetes were at a minimally or insignificantly higher risk of all‐cause and cancer‐specific death, whereas those with complicated diabetes had 85% higher odds of death from any cause and 41% higher odds of death from cancer. These associations were more pronounced in women and in patients with early‐stage colorectal cancer.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Q&A: The art of diabetes care—why precision medicine leads to better diabetes careDiabetes can show up in almost anyone: pregnant women, babies, kids, teens, adults both young and old.
Read more »
Does diabetes affect the survival of individuals with colorectal cancer?Complications of diabetes can have numerous negative health effects, from impaired vision and nerve damage to kidney dysfunction and heart disease. In an analysis of information on adults with colorectal cancer, patients who also had diabetes—particularly those with diabetic complications—faced a higher risk of dying early.
Read more »
COVID-19 tied to elevated risk of benign prostatic hyperplasia complicationsSARS-CoV-2 infection linked to increased benign prostatic hyperplasia (BPH) complications and medication use. Urological manifestations in COVID-19 patients emphasize the importance of awareness among clinicians.
Read more »
Empowerment boosts resilience: Stigma's role in diabetes patients' quality of lifeA Chinese study reveals how empowerment influences the quality of life of diabetic patients by moderating the impact of stigma.
Read more »
Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatmentIn a study published in Scientific Reports, researchers engineer long-lasting GLP-1 receptor agonists by fusing GLP-1 with an HSA-binding protein. These chimeric molecules show promise for the treatment of type 2 diabetes due to their stability, functionality, and high affinity for the GLP-1 receptor and human serum albumin.
Read more »